AAME
Atlantic American Corporation
There isn't enough reported data to score AAME yet.
BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
AAME Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
AAME's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like AAME.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
AAME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 4.3x | $1.19 | — |
| Cheap | 5.4x | $1.51 | +27% |
| Fair | 14x | $3.87 | +225% |
| Expensive | 34x | $9.41 | +690% |
Historical ranges are pointers, not guarantees.
AAME has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
AAME Forward outlook
There aren't enough analyst estimates for AAME to show an outlook.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
AAME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.28 | +$0.51 |
| Q3 2025 | $0.21 | +$0.56 |
| Q2 2025 | $0.09 | +$0.26 |
| Q1 2025 | -$0.10 | -$0.05 |
| Q4 2024 | -$0.23 | -$0.20 |
| Q3 2024 | -$0.35 | -350% |
| Q2 2024 | -$0.17 | -950% |
| Q1 2024 | -$0.05 | +$0.10 |
AAME has the stronger earnings trend. Trailing diluted EPS is up 22% for AAME versus BAC up 14%.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
AAME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $51.3M | +4.5% |
| Q3 2025 | $53.8M | +21% |
| Q2 2025 | $55.3M | +16% |
| Q1 2025 | $50.1M | +6.7% |
| Q4 2024 | $49M | +4.9% |
| Q3 2024 | $44.5M | -0.2% |
| Q2 2024 | $47.7M | -3.1% |
| Q1 2024 | $47M | +1.6% |
BAC has the stronger quarterly revenue trend. Revenue is up 4.5% for AAME versus up 6.7% for BAC.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 3.3% | +2.2 points |
| Q3 2025 | 1.4% | +6.9 points |
| Q2 2025 | 7.6% | +9.4 points |
| Q1 2025 | 2.1% | +7.4 points |
| Q4 2024 | 1.1% | +7.8 points |
| Q3 2024 | -5.5% | -10 points |
| Q2 2024 | -1.8% | -6.3 points |
| Q1 2024 | -5.3% | -1.4 points |
AAME's operating margin was 3.3% last quarter, up 2.2 points from the same quarter a year ago.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
AAME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $17.7M | +86% |
| Q3 2025 | $6.6M | +11298% |
| Q2 2025 | $9.1M | +2423% |
| Q1 2025 | -$986K | +$4.4M |
| Q4 2024 | $9.5M | +54% |
| Q3 2024 | $58K | -96% |
| Q2 2024 | $361K | -95% |
| Q1 2024 | -$5.4M | +$6.3M |
AAME has the stronger cash trend. Its trailing FCF is up 504% versus its history, compared with BAC at up 119%.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
AAME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1K shares |
| 1 year | 0% | -2K shares |
| 3 years | 0% | +8K shares |
| 5 years | -6.5% | -1.4M shares |
| Available history | -5.3% | -1.1M shares |
AAME has 20M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
| Q3 2019 | — |
| Q2 2019 | $22,000 |
| Q1 2019 | $49,000 |
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over AAME on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
AAME Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -4.7x | Net Cash |
| Q3 2025 | -4.4x | Net Cash |
| Q2 2025 | -11.6x | Net Cash |
| Q4 2023 | -290.6x | Net Cash |
| Q3 2023 | -4.5x | Net Cash |
| Q2 2023 | -13.3x | Net Cash |
| Q4 2022 | -9.0x | Net Cash |
| Q3 2022 | -4.1x | Net Cash |
AAME has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like AAME.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
AAME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.3 | Neutral |
| Stochastic | 16.6 | Oversold |
AAME's weekly RSI is 37 (neutral) and its Stochastic is 17 (oversold).
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
AAME PE vs Financial Services Sector
| Metric | AAME | Sector median | Relative |
|---|---|---|---|
| PE | 4.3x | 13x | 67% below |
| PE % | 5 | 63 | 58 pts below |
AAME has the edge over BAC on valuation relative to its sector.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
AAME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.18 | 0.8% above |
| 20 week MA | $1.36 | 13% below |
| 50 week MA | $2.04 | 42% below |
| 100 week MA | $2.08 | 43% below |
| 200 week MA | $2.05 | 42% below |
AAME has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 42% below its 200-week average.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
AAME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.85 | $2.08 | +12% |
| 2021 | $2.08 | $3.21 | +54% |
| 2022 | $3.21 | $2.42 | -25% |
| 2023 | $2.42 | $2.45 | +1.2% |
| 2024 | $2.45 | $1.48 | -40% |
| 2025 | $1.48 | $2.55 | +72% |
| 2026 YTD | $2.55 | $1.19 | -53% |
AAME is down 53% so far in 2026, after finishing higher in four of the previous six years.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over AAME on returns for 2026, with the stronger performance.